Drug Metabolism and Bioanalysis Letters

Drug Metabolism and Bioanalysis Letters is an interdisciplinary, peer-reviewed journal that publishes letters, original research papers, mini-reviews, and guest-edited issues in all important aspects of drug metabolism, pharmacokinetics, and bioanalysis.

The scope includes in vitro systems, including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; bioactivation; recent developments for the identification of drug metabolites, reactive intermediate, and glutathione conjugates.

Additionally, LC/MS and other key detection methods, including ligand binding assays, sample preparation, chromatography and separation sciences, and method development and validation, are included, with applications in drug and metabolite assays, pharmacokinetic/toxicokinetic assays, biomarker assays, immunogenicity assays, diagnostic assays. Topics covered in this interdisciplinary journal include:

Drug Metabolism and Bioanalysis Letters is an international, peer-reviewed journal on all aspects of drug metabolism and bioanalysis published half-yearly (print & online) by Bentham Science Publishers.